U.S. market Open. Closes in 3 hours 42 minutes

JAZZ | Jazz Pharmaceuticals plc Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for JAZZ we got that it has average fundamentals where Valuation is considered to be significantly undervalued, Profitability is very poor, Growth is good and Health is very weak.

Valuation (86%)

Company Industry
P/E Ratio (TTM) 17.44 -23.05
PEG Ratio (TTM) 0.87 15.47
P/S Ratio (TTM) 1.73 49.46
P/B Ratio (TTM) 1.83 18.87
P/FCF Ratio (TTM) 6.48 -3.27
Price to 5YR AVG Earnings Ratio 49.24 -3.55
Price to 5YR AVG FCF Ratio 9.17 -9.37

Profitability (40%)

Company Industry
ROA (TTM) 3.48% -5.14%
ROE (TTM) 10.76% 16.69%
Net Profit Margin (TTM) 10.10% -1,583.93%
ROIC 5YR AVG 7.56% 15.15%

Growth (62%)

4QTR AVG 3YR AVG 5YR AVG
EPS 289.30% -86.19% 14.18%
Revenue 2.07% 18.19% 15.52%
Net Income 285.58% -91.74% 10.68%
Cash Flow 10.42% -0.14% 9.77%

Health (39%)

Company Industry
Current Ratio (TTM) 2.25 6.13
Quick Ratio (TTM) 1.90 5.85
D/E Ratio (TTM) 1.52 -15.81
Interest Coverage (TTM) 2.25 -1.57
Piotroski F-Score 5 5
Altman Z-Score 1.36 14.12
LTL to 5YR AVG FCF 6.92 0.17
Shares Outstanding Growth 5YR AVG 1.18% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙